<DOC>
	<DOCNO>NCT00626236</DOCNO>
	<brief_summary>It hypothesize , give low effective dose , favorable side effect profile combine 's low propensity weight gain would make SPN-810 candidate treatment persistent serious conduct problem pediatric subject ADHD .</brief_summary>
	<brief_title>Phase 2a Study Safety Tolerability SPN-810 Children With ADHD Persistent Serious Conduct Problems</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Conduct Disorder</mesh_term>
	<criteria>1 . Healthy pediatric male female subject , age 6 12 year . 2 . Diagnostic Statistical Manual Mental Disorders IV Text Revision ( DSMIVTR ) diagnosis ADHD . 3 . NCBRFTIQ disruptive behavior disorder subscale 27 great baseline ; AND score 2 least 1 follow 3 item conduct problem subscale : knowingly destroy property , get physical fight , physically attack people . 4 . IQ great 71 . 1 . Current lifetime diagnosis bipolar disorder , posttraumatic stress disorder , personality disorder , psychosis otherwise specify . 2 . Currently meet DSMIVTR criterion major depressive disorder , obsessive compulsive disorder , pervasive developmental disorder . 3 . Any anxiety disorder primary diagnosis . 4 . Use anticonvulsant , antidepressant , lithium , carbamazepine , valproic acid , cholinesterase inhibitor within 2 week baseline . 5 . Unstable endocrinological neurological condition confound diagnosis contraindication treatment antipsychotic .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>ADHD conduct problem</keyword>
</DOC>